Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$116K Buy
1,019
+146
+17% +$14.5K ﹤0.01% 906
2026
Q1
$82.2K Buy
+873
New +$87.1K ﹤0.01% 944
2025
Q4
Sell
-636
Closed -$53.9K 1122
2025
Q3
$53.9K Buy
+636
New +$50.3K ﹤0.01% 892
2025
Q2
Sell
-575
Closed -$34.8K 1140
2025
Q1
$34.8K Sell
575
-253
-31% -$17.6K ﹤0.01% 964
2024
Q4
$57.2K Buy
828
+173
+26% +$12.3K ﹤0.01% 846
2024
Q3
$43.3K Sell
655
-1,533
-70% -$97.8K ﹤0.01% 910
2024
Q2
$125K Buy
2,188
+1,329
+155% +$75.3K ﹤0.01% 744
2024
Q1
$53.9K Buy
+859
New +$51.6K ﹤0.01% 854

Other funds holding INCY

Mather Group's INCY Position: Q2 2026 in Review

Mather Group increased its Incyte (INCY) stake by 17% in Q2 2026, buying an estimated $14.5K and bringing the position to 1,019 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #906.

Mather Group first reported a position in INCY in Q1 2024 and has held it in 8 quarters since. The position peaked at $125K in Q2 2024. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Mather Group held 1,019 shares of Incyte worth $116K as of Q2 2026.
  • Mather Group bought 146 Incyte shares in Q2 2026, an estimated $14.5K.
  • Incyte made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #906 holding.
  • Mather Group first reported a position in Incyte in Q1 2024 and has held it in 8 quarters since.
  • Mather Group's Incyte position peaked at $125K in Q2 2024.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.